Recruiting A Study of Lorigerlimab in Participants With Advanced Solid Tumors NCT06730347 Conditions Clear Cell Adenocarcinoma of Cervix, Clear Cell Adenocarcinoma of Fallopian Tube, Clear Cell Adenocarcinoma of Ovary, +20 more Locations UCLA — Los Angeles, California, United States Ochsner MD Anderson Cancer Center — New Orleans, Louisiana, United States START Midwest — Grand Rapids, Michigan, United States West Penn Allegheny Health — Pittsburgh, Pennsylvania, United States View all 16 locations View more locations Show fewer locations Loading locations... View Trial Details
